View Author
t-all mef 2c ptpn 2 expression figure cluster patient identi fied 2-1 ba /f cells identi lymphoblastic leukemia leukemia cancer nkx 2-1 control mutation oncogenic rearrangement jak 1 analysis protein sample lymphoblastic t-all cases level jak 1 mutations proliferative study blood oncogene t-cell mef 2c expression jak 1 mutants deletion factor table result transformation kinase inhibitor lmo 2 fusion transcription 2-5 sirna number knockdown 214-abl t cell development erasmus mc tyrosine subgroups shrna-control analyses chromosomal tlx 1-rearranged cases translocation ptpn 2 expression jak inhibitor i unsupervised shrna-ptpn lyl 1 method ptpn 2 inactivation nkx 2-1 rearrangements activation 2-2 april proliferation nkx 2-1/nkx elsevier fication ª2011 pathway nkx 2-5 soulier experiment growth sequence
2 Most Recent Publications
|
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia
(Article)
Kleppe, M. Soulier, J. Tartaglia, M. Foa, R. Macintyre, E. Haferlach, T. Cools, J. Asnafi, V. Mentens, N. Hornakova, T. Knoops, L. Constantinescu, S. Sigaux, F. Meijerink, J.P.P. Vandenberghe, P. |
2011-06-30
|
|
Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia
(Article)
Homminga, I. Pieters, R. Vlierberghe, P. van Ferrando, A.A. Cayuela, J.M. Verhaaf, B. Beverloo, H.B. Horstmann, M. Haas, V. de Wiekmeijer, A.-S. Pike-Overzet, K. Staal, F.J.T. Langerak, A.W. Laat, W.L. de Soulier, J. Sigaux, F. Meijerink, J.P.P. Rooi, J.J. de Stubbs, A. Verstegen, M.M.A. Vuerhard, M.J. Buijs-Gladdines, J.G.C.A.M. Kooi, C. Klous, P. |
2011-04-12
|